Persister Development by Borrelia burgdorferi Populations In Vitro

被引:34
|
作者
Caskey, John R. [1 ]
Embers, Monica E. [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70433 USA
关键词
STOCHASTIC GENE-EXPRESSION; LYME-DISEASE; ANTIBIOTIC-TREATMENT; PHENOTYPIC TOLERANCE; ESCHERICHIA-COLI; RESISTANCE; KINETICS; BACTERIA; CELLS; MICE;
D O I
10.1128/AAC.00883-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Doxycycline is an antibiotic commonly used to treat Lyme disease and other bacterial infections. The MIC and minimum bactericidal concentration (MBC) for Borrelia burgdorferi have been investigated by different groups but were experimentally established in this study as a function of input cell density. We demonstrated that B. burgdorferi treated in the stationary phase has a higher probability of regrowth following removal of antibiotic. In addition, we determined experimentally and mathematically that the spirochetes which persist posttreatment do not have a longer lag phase but exhibit a lower growth rate than untreated spirochetes. Finally, we found that treating the spirochetes by pulse-dosing did not eliminate growth or reduce the persister population in vitro. From these data, we propose that B. burgdorferi persister development is stochastic and driven by slowed growth.
引用
收藏
页码:6288 / 6295
页数:8
相关论文
共 50 条
  • [1] Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
    Feng, Jie
    Shi, Wanliang
    Zhang, Shuo
    Zhang, Ying
    [J]. EMERGING MICROBES & INFECTIONS, 2015, 4
  • [2] Antibodies to Borrelia burgdorferi in European populations
    Gutiérrez, J
    Guerrero, M
    Nuñez, F
    Soto, MJ
    Piédrola, G
    Maroto, MD
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2000, 14 (01) : 20 - 26
  • [3] In vitro activity of trimethoprim against Borrelia burgdorferi
    Reisinger, EC
    Wendelin, I
    Gasser, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (06) : 458 - 460
  • [4] Characterization of Biofilm Formation by Borrelia burgdorferi In vitro
    Sapi, Eva
    Bastian, Scott L.
    Mpoy, Cedric M.
    Scott, Shernea
    Rattelle, Amy
    Pabbati, Namrata
    Poruri, Akhila
    Burugu, Divya
    Theophilus, Priyanka A. S.
    Pham, Truc V.
    Datar, Akshita
    Dhaliwal, Navroop K.
    MacDonald, Alan
    Rossi, Michael J.
    Sinha, Saion K.
    Luecke, David F.
    [J]. PLOS ONE, 2012, 7 (10):
  • [5] Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
    Sharma, Bijaya
    Brown, Autumn V.
    Matluck, Nicole E.
    Hu, Linden T.
    Lewis, Kim
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4616 - 4624
  • [6] NMR metabolome of Borrelia burgdorferi in vitro and in vivo in mice
    Glader, Otto
    Puljula, Elina
    Jokioja, Johanna
    Karonen, Maarit
    Sinkkonen, Jari
    Hytonen, Jukka
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Antibiotics and increased temperature against Borrelia burgdorferi in vitro
    Reisinger, E
    Wendelin, I
    Gasser, R
    Halwachs, G
    WildersTruschnig, M
    Krejs, G
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (02) : 155 - 157
  • [8] In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi
    Kraiczy, P
    Weigand, J
    Wichelhaus, TA
    Heisig, P
    Backes, H
    Schäfer, V
    Acker, G
    Brade, V
    Hunfeld, KP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2486 - 2494
  • [9] NMR metabolome of Borrelia burgdorferi in vitro and in vivo in mice
    Otto Glader
    Elina Puljula
    Johanna Jokioja
    Maarit Karonen
    Jari Sinkkonen
    Jukka Hytönen
    [J]. Scientific Reports, 9
  • [10] Stability of Borrelia burgdorferi bdr loci in vitro and in vivo
    Zückert, WR
    Barbour, AG
    [J]. INFECTION AND IMMUNITY, 2000, 68 (03) : 1727 - 1730